You are newly hired as a mid-level leader at a large nonprofit healthcare system in the upper Midwest. One of your tasks is to advise senior leadership on strategic initiatives related to stem cell research and applications that may be added to your institution. There is a new stem cell therapy called “XYZ” that is becoming significantly popular in Europe and just recently received FDA approval in the U.S. However, this therapy requires specific stem cell materials from aborted fetuses and you work for a Catholic health system. How do you advise senior leaders on this opportunity that is quite lucrative and in need given a 20% increase in expenses last year due to Covid and non-reimbursement for services?